We are assessing how the oral medication ABBV-453 affects adults with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma. The study focuses on understanding its side effects and how it moves through the body.
Health conditions and diseases that the clinical trial is designed to study and treat.
Chronic Lymphocytic Leukemia (CLL) is a type of cancer that affects the blood and bone marrow, leading to the overproduction of abnormal lymphocytes, which can cause symptoms like fatigue, swollen lymph nodes, and frequent infections.
Small Lymphocytic Lymphoma (SLL) is a type of cancer that is closely related to Chronic Lymphocytic Leukemia (CLL) and primarily affects the lymph nodes, causing symptoms such as swollen lymph nodes and fatigue.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.
